Open AccessScreening for primary aldosteronism: How to adjust existing antihypertensive medications to avoid diagnostic errors
Author(s) -
Taylan Gurgenci,
Sam Geraghty,
Martin Wolley,
Jun Yang
Publication year - 2020
Publication title -
australian journal of general practice
Language(s) - English
Resource type - Journals
eISSN - 2208-7958
DOI - 10.31128/ajgp-07-19-4995
Subject(s) - primary aldosteronism , medicine , moxonidine , prazosin , primary care , referral , intensive care medicine , hydralazine , secondary hypertension , aldosterone , blood pressure , receptor , family medicine , antagonist , agonist
Screening for primary aldosteronism is infrequently performed in primary care. This is partly because screening is complicated by the need to adjust existing antihypertensive medications. This article provides an approach to screening patients who are already taking antihypertensive medication.